knowledge -WSS

knowledge

author：hotspot 2025-08-04 12:29:50 - browse：9

Coronary medical stent -- health business coverage from STAT — Adobe

Coronary stenting is, by some measures, the most overused procedure in hospitals. The problem costs the health system millions and unnecessarily exposes patients to risks of blood clots, torn arteries, infections, and other life-threatening injuries.

In 2020, Medicare started paying physicians to place stents, balloons, and perform other procedures designed to open clogged coronary arteries outside of hospitals, in less expensive outpatient settings. It didn’t take long for private equity firms to catch on. They’ve been racing to buy up cardiology practices ever since, rolling them into bigger and bigger chains with an eye toward reselling them at a profit.

It’s similar to what happened with orthopedics and gastroenterology, two specialties that have become saturated with private equity money since more procedures went outpatient. Research in other specialties has shown that these financial investors tend to usher in more patients, ramp up surgeries, and jack up prices, effectively increasing spending even as government policies try to lower it. Now, experts say they fear the same thing could happen in cardiology, a field with a long track record of overuse.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Millions may soon lose Medicaid when they don't have to

knowledge

WSS

Dexcom's push to bring CGM to type 2 diabetes patients

Biogen nominates mother of director’s child to replace him on board

Security flaws in third

AstraZeneca lung cancer study comes in below expectations

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Crowdfunding for unproven stem cell procedures spreads misinformation

hotspot

knowledge

Wikipedia

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Timeline: Key moments in fight for gay rights

At least 13 dead in Texas as scorching temps continue

The biotech scorecard for Q3: 15 stock

Apple is now the first public company to be valued at $3 trillion

Hubble vs. James Webb telescope images: See the difference

Medical leaders decry Supreme Court decision on affirmative action

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Moonlake's readout produced a cash windfall. Risks remain

Security flaws in third

knowledge

Use doctors trained outside the U.S. to ease the physician shortage

Can medical device makers keep up in the race to treat obesity?

Bispecific antibodies are next new thing in cancer immunotherapy

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Senate panel passes drug pricing bills, but drops one PBM reform

leisure time

entertainment

knowledge

hotspot